{"id":1512,"date":"2017-05-24T14:49:57","date_gmt":"2017-05-24T12:49:57","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/?page_id=1512"},"modified":"2018-01-17T13:50:02","modified_gmt":"2018-01-17T12:50:02","slug":"scientific-program-2017","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/en\/archive\/semmelweis-symposium-2017\/scientific-program-2017\/","title":{"rendered":"Scientific Program 2017."},"content":{"rendered":"

Scientific Program
\n <\/strong>(download here in .PDF<\/a>)
\n <\/strong><\/p>\n

9th November 2017.<\/strong><\/span><\/p>\n

09.00 Opening Ceremony<\/strong>
\n \u00c1goston Sz\u00e9l<\/strong>
\n rector, Semmelweis University<\/span><\/p>\n

09.15-13.00 Section I.
\n Emerging viral infections<\/strong><\/span><\/p>\n

D\u00f3ra Szab\u00f3<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n History of the Medical Microbiology Institute
\n J\u00f3zsef Ongr\u00e1di<\/strong><\/span>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Studies on adenoviruses at the Institute of Microbiology
\n Orsolya Dobay<\/strong><\/span>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n The Adenovirus Research Group of the Hungarian Academy of Sciences, 1995-1998
\n Dario Di Luca<\/span><\/strong>
\n University of Ferrara, Italy<\/span><\/em>
\n HHV-6 and inhibitory KIR2DL2 NK cell receptor
\n J\u00f3zsef Ongr\u00e1di<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n In vitro studies on the immunomodulatory aspects of HHV-6 and HHV-7 \u2013 associated encephalitis<\/span><\/span><\/span><\/p>\n

11.00-11.20 Coffee Break
\n <\/span><\/span><\/p>\n

Davide Abate<\/strong>
\n Unverstiy of Padova, Italy<\/em>
\n New challenges in CMV infections<\/span>
\n Erwin Tschachler<\/strong>
\n Vienna, Austria<\/em>
\n The 35 years of HIV\/AIDS \u2013What next?<\/span>
\n K\u00e1roly Nagy<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Contribution of advanced molecular biology to the HIV surveillance in Hungary<\/span><\/span>
\n <\/span><\/p>\n

13.00-14.00 Lunch<\/p>\n

14.00-17.00 Section I.
\n Emerging viral infections pt. 2<\/strong><\/span><\/p>\n

Anna-Bella Failloux<\/strong>
\n Institut Pasteur, Paris, France<\/em>
\n Vector-borne diseases threatening europe: dengue, chikungunya, zika<\/span>
\n Zolt\u00e1n Kis<\/strong>
\n National Center for Epidemiology, Hungary<\/em>
\n The Ebola outbreak \u2013 is it over?<\/span>
\n Orsolya Nagy<\/strong>
\n National Center for Epidemiology, Hungary<\/em>
\n Laboratory diagnosis of Zika virus<\/span><\/p>\n

11.00-11.20 Coffee Break<\/p>\n

M\u00e1ria Tak\u00e1cs<\/strong>
\n National Center for Epidmeiology, Hungary<\/em>
\n Hepatitis B and C genotypes in Hungary<\/span>
\n L\u00e1szl\u00f3 R\u00f3kusz<\/strong>
\n National Healthcare Services Center, Hungary<\/em>
\n The experience with the treatment of hepatitis C infection<\/span>
\n Csaba Jeney<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n The evolution of molecular diagnostic in HPV<\/span><\/p>\n

18.00 Offical Dinner<\/span><\/p>\n

10th November 2017.<\/strong><\/span><\/p>\n

8.00-10.40 Section II.
\n The challenges of the multidrug resistant bacteria and new therapeutic approaches<\/strong><\/span><\/p>\n

Christian Giske<\/strong>
\n Karolinska Institute, Stockholm, Sweden<\/em>
\n Global trends in the antimicrobial resistance<\/span>
\n B\u00e9la Kocsis<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Multidrug resistant Gram-negative bacteria in Hungary<\/span>
\n \u00c1kos T\u00f3th<\/strong>
\n National Center for Epidemiology, Hungary<\/em>
\n Multi-drug resistant Gram-positive bacteria in Hungary<\/span>
\n Mark van der Linden<\/strong>
\n Germany<\/em>
\n Global trends in the seroprevalence in Streptococus pneumoniae<\/span><\/p>\n

09.40-09.50 Coffee break<\/p>\n

Orsolya Dobay<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Pneumococci carried by healthy children in Hungary, 2009-2015<\/span>
\n Endre Ludwig<\/strong>
\n Joined Saint Stephan and Saint Ladislaus Hospital-Clinic, Budapest, Hungary<\/em>
\n Antibiotic therapy in the age of multiresistant bugs \u2013 a clinician\u2019s approach<\/span>
\n Mikl\u00f3s F\u00fczi<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Dissimilar fitness associated with resistance to fluoroquinolones influences clonal dynamics of various multiresistant bacteria<\/span><\/p>\n

10.40-11.00 Coffee break
\n <\/span><\/p>\n

11.00-13.00 Section II.
\n The challenges of the multidrug resistant bacteria and new therapeutic approaches pt. 2
\n <\/strong><\/span><\/p>\n

Carl Kraus<\/strong>
\n Raleigh-Durham, USA<\/em>
\n FDA Pathways to Antibiotic Approval<\/span>
\n Ralf Hoffmann<\/strong>
\n Leipzig, Germany<\/em>
\n Mechanistic studies on short proline-rich antimicrobial peptides<\/span>
\n L\u00e1szl\u00f3 \u00d6tv\u00f6s<\/strong>
\n Temple University, Philadelphia, USA<\/em>
\n Are the peptid antibiotics the future?<\/span>
\n Eszter Ostorh\u00e1zi<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Experiences with the A3-APO<\/span><\/p>\n

13.00-14.00 Lunch<\/span><\/p>\n

14.00-17.00 Section III.
\n The importance of the human microbiome<\/strong><\/span><\/p>\n

Sean Kennedy<\/strong>
\n Institut Pasteur, Paris, France<\/em>
\n The bioinformatical analysis of the microbiome<\/span>
\n D\u00f3ra Szab\u00f3<\/strong>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n The effect of the antibiotics on the microbiome<\/span>
\n Zsolt Rad\u00e1k<\/strong>
\n University of Physical Education, Hungary<\/em>
\n The sport and the microbiome<\/span><\/p>\n

15.30-15.40 Coffee break<\/p>\n

Krisztina Mad\u00e1ch<\/strong>
\n Semmelweis University, Hungary<\/em>
\n The role of the microbiome in the intensive care<\/span>
\n G\u00e1bor Veres<\/strong>
\n Semmelweis University, Hungary<\/em>
\n The Characteristics of microbiome in pediatric- and adult patients Chron\u2019s disease<\/span>
\n S\u00e1ndor Pongor, J\u00e1nos Juh\u00e1sz, Bal\u00e1zs Ligeti, Attila J\u00e1dy<\/strong>
\n P\u00e9ter P\u00e1zm\u00e1ny Catholic University, Hungary<\/em>
\n Molecular signaling mechanisms underlying the stability of microbial communities
\n D\u00f3ra Szab\u00f3<\/strong><\/span>
\n Institute of Medical Microbiology, Semmelweis University, Hungary<\/em>
\n Closing remarks<\/p>\n

<\/span><\/p>\n

Test<\/strong><\/p>\n

Section IV.
\n Poster Section<\/strong><\/p>\n

P. 1. Balint Gergely Szabo 1,2,3,<\/sup> Tamas Tirczka 4,<\/sup> Eszter Ostorhazi 5<\/sup>
\n <\/strong>1 Joined Saint Stephan and Saint Ladislaus Hospital\u2013Clinic, Department of Infectology (Budapest, Hungary)
\n 2 Semmelweis University, Faculty of Medicine, Infectious Disease Specialist Training (Budapest, Hungary)
\n 3 Semmelweis University, Doctoral School of Clinical Medicine (Budapest, Hungary)
\n 4 National Center for Epidemiology (Budapest, Hungary)
\n 5 Semmelweis University, Institute of Medical Microbiology (Budapest, Hungary)
\n <\/em>Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 12-year single center experience<\/span><\/p>\n

P.2. Balint Gergely Szabo 1,2,3,<\/sup> Rebeka Kiss 4<\/sup>, Katalin Szidonia Lenart 1,2,<\/sup> Botond Lakatos 1,<\/sup> Eszter Ostorhazi <\/strong>5,<\/sup><\/strong> Janos Szlavik 1<\/sup>
\n <\/strong>1 Joined Saint Stephan and Saint Ladislaus Hospital\u2013Clinic, Department of Infectology (Budapest, Hungary)
\n 2 Semmelweis University, Faculty of Medicine, Infectious Disease Specialist Training (Budapest, Hungary)
\n 3 Semmelweis University, Doctoral School of Clinical Medicine (Budapest, Hungary)
\n 4 Semmelweis University, Faculty of Medicine, Students’ Scientific Association (Budapest, Hungary)
\n <\/em>Clinical and microbiological characteristics and outcomes of community acquired sepsis: results of a single center, 1-year retrospective observational cohort study<\/span><\/p>\n

P.3.Katalin Szidonia Lenart 1,2,<\/sup> Balint Gergely Szabo 1,2,3,<\/sup> Bela Kadar 1,2,4,<\/sup> Radka Nikolova 5,<\/sup> Gyula Prinz 1,<\/sup> Janos Szlavik 1
\n <\/sup><\/strong>1 Joined Saint Stephan and Saint Ladislaus Hospital\u2013Clinic, Department of Infectology (Budapest, Hungary)
\n <\/em>2 Semmelweis University, Faculty of Medicine, Infectious Disease Specialist Training (Budapest, Hungary)
\n <\/em>3 Semmelweis University, Doctoral School of Clinical Medicine (Budapest, Hungary)
\n <\/em>4 Semmelweis University, Institute of Medical Microbiology (Budapest, Hungary)
\n <\/em>5Joined Saint Stephan and Saint Ladislaus Hospital\u2013Clinic, Core Microbiology Laboratory (Budapest, Hungary)
\n <\/em>Species\/serotype distribution and antibiotic susceptibility of Salmonella <\/em>and Campylobacter <\/em>sp. isolated from human disease: results of a 1-year observational, microbiological study from Hungary<\/span><\/p>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

Scientific Program ( download here in .PDF<\/a> ) 9th November 2017. 09.00 Opening Ceremony \u00c1goston Sz\u00e9l rector, Semmelweis University 09.15-13.00 Section I. Emerging viral infections D\u00f3ra Szab\u00f3 Institute of Medical Microbiology, Semmelweis University, Hungary History of the Medical Microbiology Institute J\u00f3zsef Ongr\u00e1di Institute of Medical Microbiology, Semmelweis University, Hungary Studies on adenoviruses at the Institute of Microbiology Orsolya Dobay …<\/p>\n","protected":false},"author":182,"featured_media":0,"parent":1452,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-1512","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/182"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=1512"}],"version-history":[{"count":12,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1512\/revisions"}],"predecessor-version":[{"id":1663,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1512\/revisions\/1663"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1452"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=1512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=1512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=1512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}